Literature DB >> 14566786

Optimal heparin surface concentration and antithrombin binding capacity as evaluated with human non-anticoagulated blood in vitro.

Jonas Andersson1, Javier Sanchez, Kristina Nilsson Ekdahl, Graciela Elgue, Bo Nilsson, Rolf Larsson.   

Abstract

Contact between blood and a biomaterial surface takes place in many applications and is known to activate the coagulation and complement systems. Heparin surface coatings have been shown to reduce blood activation upon contact with artificial surfaces. To establish the optimal heparin surface concentration, blood was incubated in a tubing loop model at 37 degrees C. The tubing was coated with different surface concentrations of heparin and rotated at three different velocities. We demonstrate that the blood compatibility of a surface with regard to coagulation, complement, and platelet activation can be improved by increasing the heparin surface concentration in the 6-12 pmol antithrombin/cm2 concentration interval. The binding of factor H is not influenced by the increased heparin surface concentration, suggesting that this factor is not the primary regulator of complement on heparin surfaces. In addition, the heparin coating has no effect on the complement activation that occurs on gas surfaces in extracorporeal circuits. Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14566786     DOI: 10.1002/jbm.a.10104

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  17 in total

1.  Neutrophilic granulocytes are the predominant cell type infiltrating pancreatic islets in contact with ABO-compatible blood.

Authors:  L Moberg; O Korsgren; B Nilsson
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

2.  A new method for incorporating functional heparin onto the surface of islets of Langerhans.

Authors:  Sanja Cabric; Torsten Eich; Javier Sanchez; Bo Nilsson; Olle Korsgren; Rolf Larsson
Journal:  Tissue Eng Part C Methods       Date:  2008-06       Impact factor: 3.056

3.  Attachment of flexible heparin chains to gelatin scaffolds improves endothelial cell infiltration.

Authors:  Jonas Leijon; Fredrik Carlsson; Johan Brännström; Javier Sanchez; Rolf Larsson; Bo Nilsson; Peetra U Magnusson; Magnus Rosenquist
Journal:  Tissue Eng Part A       Date:  2013-02-26       Impact factor: 3.845

4.  In vivo evaluation of a new surfactant polymer coating mimicking the glycocalyx of endothelial cells.

Authors:  Akira Shiose; Tohru Takaseya; Hyun-Il Kim; Mariko Kobayashi; Tetsuya Horai; Santosh Rao; Yoko Arakawa; Masako Fujiki; Mark A McCarthy; Yubiao Liu; Jan J Lewandowski; Amy Davis; Kiyotaka Fukamachi
Journal:  ASAIO J       Date:  2011 Sep-Oct       Impact factor: 2.872

5.  Anchoring of vascular endothelial growth factor to surface-immobilized heparin on pancreatic islets: implications for stimulating islet angiogenesis.

Authors:  Sanja Cabric; Javier Sanchez; Ulrika Johansson; Rolf Larsson; Bo Nilsson; Olle Korsgren; Peetra U Magnusson
Journal:  Tissue Eng Part A       Date:  2010-03       Impact factor: 3.845

6.  Simulated Thrombin Generation in the Presence of Surface-Bound Heparin and Circulating Tissue Factor.

Authors:  E Victoria Dydek; Elliot L Chaikof
Journal:  Ann Biomed Eng       Date:  2015-07-14       Impact factor: 3.934

7.  Protection of nonself surfaces from complement attack by factor H-binding peptides: implications for therapeutic medicine.

Authors:  You-Qiang Wu; Hongchang Qu; Georgia Sfyroera; Apostolia Tzekou; Brian K Kay; Bo Nilsson; Kristina Nilsson Ekdahl; Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2011-02-21       Impact factor: 5.422

Review 8.  Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies.

Authors:  Kristina N Ekdahl; John D Lambris; Hans Elwing; Daniel Ricklin; Per H Nilsson; Yuji Teramura; Ian A Nicholls; Bo Nilsson
Journal:  Adv Drug Deliv Rev       Date:  2011-07-08       Impact factor: 15.470

Review 9.  Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis.

Authors:  Robert A DeAngelis; Edimara S Reis; Daniel Ricklin; John D Lambris
Journal:  Immunobiology       Date:  2012-11       Impact factor: 3.144

10.  Acute antibody-mediated complement activation mediates lysis of pancreatic islets cells and may cause tissue loss in clinical islet transplantation.

Authors:  Jenny Tjernberg; Kristina N Ekdahl; John D Lambris; Olle Korsgren; Bo Nilsson
Journal:  Transplantation       Date:  2008-04-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.